Atrial fibrillation in Younger Human Immunodeficiency Virus(HIV)Patient Population: Prevalence of Atrial Fibrillation Among HIV Patients Less Than 65 yearsDeepak J. Pattanshetty, MD
Patients in NYHA functional classes II–IV, with an LVEF > 40% and an elevated NT-proBNP level were eligible for DELIVER. Participants were also required to have evidence of structural heart disease (defined as either left atrial enlargement or left ventricular hypertrophy). All patients in ...
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;57(11):1330–7. CrossRef About this ...
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation. 2019;0(0):CIR0000000000000665.PubMedGoogle Scholar 9. Yavuz B, Ayturk M, Ozkan S, et al. A real world data of dabigatran etexilate: multicenter registry...
For studies that reported outcomes at more than one time point within the same 1- to 3- or 4- to 6–month window, the last time point was analyzed. Outcomes reported between 2 time points were categorized with the earlier month. Hazard ratios (HRs) were used as the treatment effect for...
Atrial fibrillation 5 (3.9) 4 (3.1) 15 (4.2) 0.84 4 (1.5) 24 (2.6) 45 (2.7) 0.49 18 (2.6) 26 (2.7) 15 (2.1) 0.74 Hypertension 71 (55.0) 84 (64.1) 238 (66.9) 0.06 110 (40.6) 499 (53.3) 1,027 (61.9) <0.001 354 (51.8) 528 (54.8) 464 (65.9) <0.001 Diabetes mellitus...
HRs are for the PPM group compared with the no-PPM group. b Multivariable models were adjusted for age, body mass index, Society of Thoracic Surgeon risk score, atrial fibrillation or flutter, chronic kidney disease, aortic valve area, mean pressure gradient, left ventricular ejection fraction, ...
Atrial fibrillation is a commonly encountered arrhythmia associated with increased risk for thromboembolic events. Anticoagulation is necessary to decrease
Patient-Specific Atrial Modeling Uncovers Link Between Fibrosis and Atrial FibrillationKathleen McDowell, BS
Device-associated adverse events were generally higher among patients classified as unlikely; the absolute risk increases in atrial fibrillation beyond day 45 after randomization with a device were 4.41% (95% CI, 1.02% to 7.80%), 1.53% (95% CI, 0.33% to 2.72%), and 0.65% (95% CI, −...